S&P 500   3,257.86 (-1.58%)
DOW   26,398.07 (-0.98%)
QQQ   268.16 (-2.98%)
AAPL   108.24 (-6.14%)
MSFT   201.20 (-1.72%)
FB   261.54 (-6.87%)
GOOGL   1,609.46 (+3.38%)
AMZN   3,029.03 (-5.67%)
TSLA   387.57 (-5.66%)
NVDA   496.86 (-4.63%)
BABA   304.82 (-2.48%)
CGC   18.74 (-0.21%)
GE   7.36 (-0.14%)
MU   50.13 (-0.69%)
AMD   74.87 (-4.04%)
T   26.90 (+0.52%)
F   7.67 (-2.91%)
ACB   4.03 (-1.47%)
GILD   57.78 (-1.28%)
NIO   30.50 (-4.66%)
NFLX   473.91 (-6.01%)
BA   143.29 (-3.37%)
DIS   120.27 (-1.04%)
S&P 500   3,257.86 (-1.58%)
DOW   26,398.07 (-0.98%)
QQQ   268.16 (-2.98%)
AAPL   108.24 (-6.14%)
MSFT   201.20 (-1.72%)
FB   261.54 (-6.87%)
GOOGL   1,609.46 (+3.38%)
AMZN   3,029.03 (-5.67%)
TSLA   387.57 (-5.66%)
NVDA   496.86 (-4.63%)
BABA   304.82 (-2.48%)
CGC   18.74 (-0.21%)
GE   7.36 (-0.14%)
MU   50.13 (-0.69%)
AMD   74.87 (-4.04%)
T   26.90 (+0.52%)
F   7.67 (-2.91%)
ACB   4.03 (-1.47%)
GILD   57.78 (-1.28%)
NIO   30.50 (-4.66%)
NFLX   473.91 (-6.01%)
BA   143.29 (-3.37%)
DIS   120.27 (-1.04%)
S&P 500   3,257.86 (-1.58%)
DOW   26,398.07 (-0.98%)
QQQ   268.16 (-2.98%)
AAPL   108.24 (-6.14%)
MSFT   201.20 (-1.72%)
FB   261.54 (-6.87%)
GOOGL   1,609.46 (+3.38%)
AMZN   3,029.03 (-5.67%)
TSLA   387.57 (-5.66%)
NVDA   496.86 (-4.63%)
BABA   304.82 (-2.48%)
CGC   18.74 (-0.21%)
GE   7.36 (-0.14%)
MU   50.13 (-0.69%)
AMD   74.87 (-4.04%)
T   26.90 (+0.52%)
F   7.67 (-2.91%)
ACB   4.03 (-1.47%)
GILD   57.78 (-1.28%)
NIO   30.50 (-4.66%)
NFLX   473.91 (-6.01%)
BA   143.29 (-3.37%)
DIS   120.27 (-1.04%)
S&P 500   3,257.86 (-1.58%)
DOW   26,398.07 (-0.98%)
QQQ   268.16 (-2.98%)
AAPL   108.24 (-6.14%)
MSFT   201.20 (-1.72%)
FB   261.54 (-6.87%)
GOOGL   1,609.46 (+3.38%)
AMZN   3,029.03 (-5.67%)
TSLA   387.57 (-5.66%)
NVDA   496.86 (-4.63%)
BABA   304.82 (-2.48%)
CGC   18.74 (-0.21%)
GE   7.36 (-0.14%)
MU   50.13 (-0.69%)
AMD   74.87 (-4.04%)
T   26.90 (+0.52%)
F   7.67 (-2.91%)
ACB   4.03 (-1.47%)
GILD   57.78 (-1.28%)
NIO   30.50 (-4.66%)
NFLX   473.91 (-6.01%)
BA   143.29 (-3.37%)
DIS   120.27 (-1.04%)
Log in
NYSE:CHE

Chemed Stock Forecast, Price & News

$477.07
+3.54 (+0.75 %)
(As of 10/30/2020 03:43 PM ET)
Add
Compare
Today's Range
$474.15
Now: $477.07
$487.80
50-Day Range
$470.82
MA: $484.59
$497.81
52-Week Range
$330.01
Now: $477.07
$528.29
Volume9,221 shs
Average Volume96,837 shs
Market Capitalization$7.59 billion
P/E Ratio29.99
Dividend Yield0.29%
Beta0.69
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio.
Read More
Chemed logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.3Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.42 out of 5 stars

Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
CUSIP16359R10
Phone513-762-6690
Employees16,641

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.94 billion
Cash Flow$16.83 per share
Book Value$45.39 per share

Profitability

Net Income$219.92 million

Miscellaneous

Market Cap$7.59 billion
Next Earnings Date2/16/2021 (Estimated)
OptionableOptionable
$477.07
+3.54 (+0.75 %)
(As of 10/30/2020 03:43 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Chemed (NYSE:CHE) Frequently Asked Questions

How has Chemed's stock been impacted by COVID-19 (Coronavirus)?

Chemed's stock was trading at $414.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CHE stock has increased by 15.1% and is now trading at $476.62.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Chemed?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Chemed
.

When is Chemed's next earnings date?

Chemed is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021.
View our earnings forecast for Chemed
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) issued its quarterly earnings results on Thursday, October, 29th. The company reported $4.86 earnings per share for the quarter, beating the Zacks' consensus estimate of $3.97 by $0.89. The company earned $528.30 million during the quarter, compared to analysts' expectations of $514.22 million. Chemed had a net margin of 12.99% and a return on equity of 36.71%. The firm's quarterly revenue was up 9.9% compared to the same quarter last year. During the same period in the previous year, the company earned $3.46 EPS.
View Chemed's earnings history
.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Thursday, August 6th. Shareholders of record on Monday, August 17th will be paid a dividend of $0.34 per share on Friday, September 4th. This represents a $1.36 dividend on an annualized basis and a yield of 0.29%. The ex-dividend date is Friday, August 14th. This is a boost from Chemed's previous quarterly dividend of $0.32.
View Chemed's dividend history
.

What guidance has Chemed issued on next quarter's earnings?

Chemed issued an update on its FY20 earnings guidance on Thursday, October, 29th. The company provided earnings per share (EPS) guidance of $18.00-18.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $16.35.

What price target have analysts set for CHE?

3 Wall Street analysts have issued 12-month price objectives for Chemed's stock. Their forecasts range from $490.00 to $535.00. On average, they expect Chemed's stock price to reach $520.00 in the next twelve months. This suggests a possible upside of 9.1% from the stock's current price.
View analysts' price targets for Chemed
.

Are investors shorting Chemed?

Chemed saw a increase in short interest in October. As of October 15th, there was short interest totaling 168,500 shares, an increase of 22.5% from the September 30th total of 137,600 shares. Based on an average daily trading volume, of 64,900 shares, the short-interest ratio is presently 2.6 days. Currently, 1.1% of the shares of the stock are sold short.
View Chemed's Short Interest
.

Who are some of Chemed's key competitors?

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), The Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

Who are Chemed's key executives?

Chemed's management team includes the following people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
  • Mr. David P. Williams, Exec. VP & CFO (Age 58)
  • Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
  • Mr. Spencer S. Lee, Exec. VP (Age 63)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 40)

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by many different institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (2.19%), Standard Life Aberdeen plc (0.68%), Assenagon Asset Management S.A. (0.63%), Copeland Capital Management LLC (0.53%), Trinity Street Asset Management LLP (0.38%) and Envestnet Asset Management Inc. (0.36%). Company insiders that own Chemed stock include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs.
View institutional ownership trends for Chemed
.

Which major investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, Copeland Capital Management LLC, Robeco Institutional Asset Management B.V., Alberta Investment Management Corp, WINTON GROUP Ltd, Dorsey Wright & Associates, Nisa Investment Advisors LLC, and First Quadrant L P CA. Company insiders that have sold Chemed company stock in the last year include Andrea R Lindell, Donald E Saunders, Frank E Wood, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Patrick P Grace, and Spencer S Lee.
View insider buying and selling activity for Chemed
.

Which major investors are buying Chemed stock?

CHE stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., North Point Portfolio Managers Corp OH, DekaBank Deutsche Girozentrale, Riverbridge Partners LLC, Envestnet Asset Management Inc., Standard Life Aberdeen plc, Pacer Advisors Inc., and Vestmark Advisory Solutions Inc..
View insider buying and selling activity for Chemed
.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $476.62.

How big of a company is Chemed?

Chemed has a market capitalization of $7.59 billion and generates $1.94 billion in revenue each year. The company earns $219.92 million in net income (profit) each year or $13.95 on an earnings per share basis. Chemed employs 16,641 workers across the globe.

What is Chemed's official website?

The official website for Chemed is www.chemed.com.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.

This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.